These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7877848)

  • 1. In vitro secretion of cytokines by human mononuclear cells of individuals during and after cutaneous leishmaniasis infection.
    Frankenburg S; Kofsky Y; Gross A
    Parasite Immunol; 1993 Sep; 15(9):509-12. PubMed ID: 7877848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major.
    Kemp M; Handman E; Kemp K; Ismail A; Mustafa MD; Kordofani AY; Bendtzen K; Kharazmi A; Theander TG
    FEMS Immunol Med Microbiol; 1998 Mar; 20(3):209-18. PubMed ID: 9566492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human cytokine response to Leishmania major early after exposure to the parasite in vitro.
    Rogers KA; Titus RG
    J Parasitol; 2004 Jun; 90(3):557-63. PubMed ID: 15270099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis.
    Kemp M; Hey AS; Kurtzhals JA; Christensen CB; Gaafar A; Mustafa MD; Kordofani AA; Ismail A; Kharazmi A; Theander TG
    Clin Exp Immunol; 1994 Jun; 96(3):410-5. PubMed ID: 8004809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma- and tumour necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis.
    Kemp K; Theander TG; Hviid L; Garfar A; Kharazmi A; Kemp M
    Scand J Immunol; 1999 Jun; 49(6):655-9. PubMed ID: 10354378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo evidence for PGE2 and LTB4 involvement in cutaneous leishmaniasis: relation with infection status and cytokine production.
    Milano S; Arcoleo F; Dieli M; D'Agostino R; De Nucci G; D'Agostino P; Cillari E
    Parasitology; 1996 Jan; 112 ( Pt 1)():13-9. PubMed ID: 8587796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential induction of TNFalpha and IL-18 in human peripheral blood mononuclear cells infected with Leishmania major or Leishmania donovani.
    Iannello D; Arena A; Buemi C; Calapai M; Stassi G; Gazzara D; Mastroeni P
    New Microbiol; 2003 Oct; 26(4):399-404. PubMed ID: 14596352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
    Skeiky YA; Guderian JA; Benson DR; Bacelar O; Carvalho EM; Kubin M; Badaro R; Trinchieri G; Reed SG
    J Exp Med; 1995 Apr; 181(4):1527-37. PubMed ID: 7699334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
    Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cutaneous leishmaniasis: in-vitro parasite--mononuclear cell interactions in immune and naive individuals.
    Gross A; Sliwa K; Frankenburg S; Wyler D; Klaus S
    Arch Dermatol Res; 1992; 284(4):209-11. PubMed ID: 1417066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia.
    Sassi A; Louzir H; Ben Salah A; Mokni M; Ben Osman A; Dellagi K
    Clin Exp Immunol; 1999 Apr; 116(1):127-32. PubMed ID: 10209516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 and interferon-gamma production by Leishmania stimulated peripheral blood mononuclear cells from nonexposed individuals.
    Kurtzhals JA; Kemp M; Poulsen LK; Hansen MB; Kharazmi A; Theander TG
    Scand J Immunol; 1995 Apr; 41(4):343-9. PubMed ID: 7899822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.
    Reiner SL; Zheng S; Wang ZE; Stowring L; Locksley RM
    J Exp Med; 1994 Feb; 179(2):447-56. PubMed ID: 7905017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major.
    Louzir H; Melby PC; Ben Salah A; Marrakchi H; Aoun K; Ben Ismail R; Dellagi K
    J Infect Dis; 1998 Jun; 177(6):1687-95. PubMed ID: 9607850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania major soluble exo-antigens (LmSEAgs) protect neonatal BALB/C mice from a subsequent challenge with L. major and stimulate cytokine production by Leishmania-naïve human peripheral blood mononuclear cells.
    Tonui WK; Titust RG
    J Parasitol; 2006 Oct; 92(5):971-6. PubMed ID: 17152936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania major: effects of proteophosphoglycan on reactive oxygen species, IL-12, IFN-gamma and IL-10 production in healthy individuals.
    Kavoosi G; Ardestani SK; Kariminia A; Zeinali M; Alimohammadian MH
    Exp Parasitol; 2008 Sep; 120(1):62-6. PubMed ID: 18558402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania major: Reactive oxygen species and interferon gamma induction by soluble lipophosphoglycan of stationary phase promastigotes.
    Kavoosi G; Ardestani SK; Kariminia A; Abolhassani M; Turco SJ
    Exp Parasitol; 2006 Dec; 114(4):323-8. PubMed ID: 16759653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.